← All candidates
42 insider filings on record.
42 filings on record.
SRPTSarepta Therapeutics, Inc.
NasdaqGS · Healthcare · $2.16B
$20.72
-4.63% · Sep 16
42 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 sell
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what SRPT ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.16B
Float
100.5M
95% public
Short % float
Pro
Price / profit
46.9
Price / future profit
8.0
Price / sales
1.1
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
37 more transactions on Pro →Context
Wall St
$22.00 avg target
+6.2% vs today · 23 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$3.16 act+$2.11
Q4 '25−$3.58 act−$2.81
Q3 '25−$0.13 act+$0.24
Q2 '25$2.02 act+$0.86
Coverage
SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne TherapiesStocktwits · 06-30Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC SaysMT Newswires · 06-18Is Sarepta (SRPT) Using New Equity Plans To Quietly Redefine Its Post‑Profitability Playbook?Simply Wall St. · 06-08All You Need to Know About Sarepta Therapeutics (SRPT) Rating Upgrade to BuyZacks · 06-08
The file stays open
42 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice